ADVFN US – Market Content Editor

Shares of Robin Energy Ltd. (NASDAQ:RBNE) surged 100% after the company confirmed it had finalized its initial $5 million Bitcoin allocation through Anchorage Digital Bank N.A. This move follows an announcement on August 5 and forms part of Robin Energy’s recently adopted treasury strategy. The global ship-owning and energy transportation company indicated it will continue…

Shares of Oracle (NYSE:ORCL) jumped 39% in early trading on Wednesday after the tech giant released an ambitious cloud revenue forecast, overshadowing first-quarter fiscal results that slightly missed analyst expectations. The surge pushed Oracle’s market capitalization to around $915.65 billion, edging it closer to the trillion-dollar valuations of peers like Microsoft and Apple. Year-to-date, the…

A new report from the Labor Department on Wednesday revealed that U.S. producer prices fell slightly in August, contrary to economists’ expectations. The decline was largely driven by a notable drop in trade service costs. The department reported that the producer price index (PPI) for final demand decreased 0.1% in August, following a revised gain…

U.S. stock futures pointed higher Wednesday, suggesting the major indexes could continue the upward momentum seen in the previous session. The gains followed the release of Labor Department data showing a modest decline in producer prices for August, surprising economists who had expected a slight increase. The producer price index for final demand edged down…

Shares of Greenwich LifeSciences (NASDAQ:GLSI) jumped 26% in premarket trading on Wednesday following news that the company’s breast cancer therapy received an important regulatory milestone. The biotech firm said its GLSI-100 treatment earned “fast track” designation from the U.S. Food and Drug Administration (FDA). “This designation is designed to accelerate the development and review process…

PMV Pharmaceuticals (NASDAQ:PMVP) stock surged 16% after the company released encouraging interim results from its Phase 2 PYNNACLE trial, evaluating rezatapopt in patients with various solid tumors carrying the TP53 Y220C mutation. The precision oncology study showed a 33% overall response rate among 97 evaluable patients across eight tumor types, with a median response duration…

Joby Aviation, Inc. (NYSE:JOBY) saw its stock climb 7.5% after announcing plans to integrate Blade’s air mobility services into the Uber app as early as next year. The move extends Joby’s strategic partnership with Uber Technologies, Inc. (NYSE:UBER) and comes on the heels of its recent acquisition of Blade’s passenger operations. Through the integration, Uber…

Avidity Biosciences (NASDAQ:RNA) gained 2% on Wednesday after releasing fresh clinical data showing that its experimental therapy del-zota reversed disease progression in patients with Duchenne muscular dystrophy (DMD44). The San Diego-based biotech said that patients who received del-zota continuously for about one year in the EXPLORE44 and EXPLORE44-OLE studies experienced “unprecedented improvement” across several functional…

Chewy, Inc. (NYSE:CHWY) saw its shares sink more than 7% on Wednesday after reporting second-quarter earnings that came in line with Wall Street forecasts and a modest revenue beat, but failed to deliver the upside investors had been hoping for. The online pet retailer reported adjusted EPS of $0.33, matching analyst estimates, while revenue reached…

CAMP4 Therapeutics Corporation (NASDAQ:CAMP) saw its stock skyrocket 200% after announcing an oversubscribed private placement that could raise up to $100 million to support its lead program targeting SYNGAP1-related disorders. The biotech firm has already raised $50 million upfront through sales of common stock at $1.53 per share and pre-funded warrants. An additional $50 million…